Back

CMR in immune checkpoint inhibitor-associated myocarditis: do standard CMR diagnostic criteria apply?

13 December 2025 (13:45 - 13:55)
Organised by: Logo
Congress Presentation Part of: CMR in contemporary cardio-oncology Myocardial Disease EACVI Premium Access EACVI 2025 European Association of Cardiovascular Imaging (EACVI)

About the speaker

Photo
Doctor Lars Michel

University of Duisburg-Essen - West-German Heart and Vascular Centre, Essen (Germany)

4 More presentations in this session

Presentation thumbnail
Role of CMR in contemporary cardio-oncology: where does it fit in?
Professor A. Barac (Fairfax, US)
Slides Video
Presentation thumbnail
CMR as biomarker of cardiotoxicity: evidence-based for CMR in cardio-oncology
Professor C. Manisty (London, GB)
Slides Video
Presentation thumbnail
Optimising the use of CMR in my cardio-oncology practice
Professor A. Ghosh (London, GB)
Slides Video
Presentation thumbnail
CMR in contemporary cardio-oncology - discussion
Video

Access the full session

Session thumbnail
CMR in contemporary cardio-oncology
Video

The Event

Event poster

EACVI 2025

13 December 2025 13:45 CET
You may be interested in
thumbnail
Congress Presentation
Diagnosis and management of immune checkpoint inhibitor-associated myocarditis: state of the art in 2023
thumbnail
Congress Presentation
Routine application of cardiac magnetic resonance imaging in patients with suspected myocarditis from immune checkpoint inhibitor therapy
thumbnail
Congress Presentation
A case of immune checkpoint inhibitor myocarditis: challenging discrepancy between markedly elevated cardiac troponin concentrations and noninvasive imaging findings

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources